Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FDA approves new ALS drug that costs $158,000 a year By: MarketWatch September 30, 2022 at 13:12 PM EDT Amylyx's new treatment for amyotrophic lateral sclerosis received funding raised during 2014's Ice Bucket Challenge. Read More >> Related Stocks: Amylyx Pharmaceuticals, Inc. - Common Stock Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
FDA approves new ALS drug that costs $158,000 a year By: MarketWatch September 30, 2022 at 13:12 PM EDT Amylyx's new treatment for amyotrophic lateral sclerosis received funding raised during 2014's Ice Bucket Challenge. Read More >> Related Stocks: Amylyx Pharmaceuticals, Inc. - Common Stock
